Continuation rather than early induction in S-1 adjuvant chemotherapy and prognosis in patients after biliary tract cancer resection.

Authors

null

Kotaro Hayashida

Nagasaki University Hospital, Nagasaki, Japan

Kotaro Hayashida , Tomohiko Adachi , Hajime Imamura , Manpei Yamashita , Hanako Tetsuo , Hajime Matsushima , Takanobu Hara , Akihiko Soyama , Kengo Kanetaka , Susumu Eguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 474)

DOI

10.1200/JCO.2024.42.3_suppl.474

Abstract #

474

Poster Bd #

B19

Abstract Disclosures

Similar Posters

First Author: Hiroaki Yanagimoto

First Author: Adam Brufsky

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.

Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.

First Author: Shogo Kobayashi